Salesforce
CRM
Apple
AAPL
Cisco
CSCO
Advanced Micro Devices
AMD
Alibaba
BABA
US Stock MarketDetailed Quotes
AEON AEON Biopharma
- 0.710
- -0.190-21.11%
Close Dec 12 16:00 ET
- 0.715
- +0.005+0.70%
Post 18:48 ET
28.38MMarket Cap2.06P/E (TTM)
0.900High0.708Low378.25KVolume0.890Open0.900Pre Close293.86KTurnover2.65%Turnover RatioLossP/E (Static)39.97MShares17.17052wk High-0.88P/B10.14MFloat Cap0.52152wk Low--Dividend TTM14.28MShs Float17.170Historical High--Div YieldTTM21.37%Amplitude0.521Historical Low0.776Avg Price1Lot Size
AEON Biopharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -2.96M | 19.52%-8.12M | 22.23%-8.6M | -10.09M | -11.06M | -25.15%-35.58M | -8.45M | -200.53%-28.43M | 78.85%-9.46M | -44.73M |
| Net income from continuing operations | ---6.17M | 1,167.12%164.11M | -569.07%-118.02M | ---15.38M | ---17.64M | 5.54%-52.56M | ---34.56M | -69.04%-55.64M | -120.53%-32.91M | --160.32M |
| Operating gains losses | --296K | ---8.81M | --43.82M | ---- | ---- | ---- | ---- | ---- | 104.31%11.24M | ---260.84M |
| Depreciation and amortization | --25K | 4.35%24K | 0.00%25K | --23K | --25K | 2,166.67%68K | --32K | --3K | --0 | --1.26M |
| Deferred tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---14.65M |
| Other non cash items | --1.88M | -11,320.10%-163.03M | 1,271.18%63.86M | --1.45M | --4.66M | -76.26%4.41M | --19.67M | 238.99%18.59M | -63.34%5.48M | --14.96M |
| Change In working capital | ---577K | -178.86%-2.11M | -82.19%96K | --2.67M | --539K | 342.66%6.27M | --4.74M | -2.48%1.42M | 2,804.00%1.45M | --50K |
| -Change in receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -593.33%-148K | --30K |
| -Change in inventory | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---7.39M |
| -Change in prepaid assets | ---1.26M | 6,150.00%363K | 217.95%124K | ---6K | --39K | -136.26%-66K | ---51K | 555.00%182K | 97.84%-40K | ---1.86M |
| -Change in payables and accrued expense | --682K | -192.43%-2.53M | -120.00%-92K | --2.74M | --460K | 416.51%6.51M | --4.79M | -23.17%1.26M | -82.90%1.64M | --9.59M |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---323K |
| -Change in other working capital | ---2K | 201.75%58K | 60.00%64K | ---57K | --40K | -569.23%-174K | ---5K | ---26K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | ---2.96M | 19.52%-8.12M | 22.23%-8.6M | ---10.09M | ---11.06M | -25.15%-35.58M | ---8.45M | -200.53%-28.43M | 78.85%-9.46M | ---44.73M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -80.00%-306K | -9K | 86.56%-170K | 98.92%-1.27M | -117.29M | |||||
| Capital expenditure reported | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---1.69M |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | -80.00%-306K | ---9K | ---170K | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 96.54%-1.27M | ---36.53M |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---79.07M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | -80.00%-306K | ---9K | 86.56%-170K | 98.92%-1.27M | ---117.29M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 50K | 25.00%10M | -16.67%5M | 8M | 6M | 198.67%40.51M | -3.99M | -44.80%13.56M | -66.44%24.57M | 73.21M |
| Net issuance payments of debt | --0 | 25.00%10M | -16.67%5M | --8M | --6M | 170.05%40.51M | ---3.99M | -40.27%15M | 159.46%25.11M | --9.68M |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --77.73M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -165.62%-1.44M | 96.19%-541K | ---14.2M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --50K | 25.00%10M | -16.67%5M | --8M | --6M | 198.67%40.51M | ---3.99M | -44.80%13.56M | -66.44%24.57M | --73.21M |
| Net cash flow | ||||||||||
| Beginning cash position | --3.44M | -66.77%1.56M | -47.08%5.16M | --4.69M | --9.75M | -74.57%5.13M | --22.2M | 218.91%20.17M | -93.35%6.32M | --95.13M |
| Current changes in cash | ---2.91M | 190.36%1.88M | 28.83%-3.6M | ---2.09M | ---5.06M | 130.70%4.62M | ---12.46M | -208.64%-15.04M | 115.59%13.84M | ---88.8M |
| End cash Position | --537K | 32.23%3.44M | -66.77%1.56M | --2.6M | --4.69M | 90.05%9.75M | --9.75M | -74.57%5.13M | 218.91%20.17M | --6.32M |
| Free cash flow | ---2.96M | 19.52%-8.12M | 22.23%-8.6M | ---10.09M | ---11.06M | -25.48%-35.89M | ---8.46M | -202.33%-28.6M | 79.62%-9.46M | ---46.42M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
